10-hydroxycamptothecin has been researched along with Angiogenesis, Pathologic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, G; Li, X; Liang, B; Liang, H; Qian, J; Wang, Y; Wu, H; Zhao, H; Zheng, C | 1 |
1 other study(ies) available for 10-hydroxycamptothecin and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Experimental evaluation of inhibitory effect of 10-hydroxycamptothecin on hypoxia-inducible factor-1α expression and angiogenesis in liver tumors after transcatheter arterial embolization.
Topics: Animals; Antineoplastic Agents, Phytogenic; Camptothecin; Catheterization; Embolization, Therapeutic; Hypoxia-Inducible Factor 1, alpha Subunit; Liver Neoplasms; Neovascularization, Pathologic; Rabbits; Treatment Outcome; Vascular Endothelial Growth Factor A | 2010 |